Celator Pharmaceuticals Corp.
Celator Technologies is a private North American biopharmaceutical company developing new carrier technology for targeting combinations of rationally selected chemotherapeutic agents to sites of diseases. Currently the Company is focused on cancer and is utilizing established drugs selected for synergistic activity in rapid, cell-based screening assays. Celator is designing products to be active against major tumor populations such as lung, colorectal, advanced breast, and ovarian cancer.
Company Details
Year Established:
2000
Company Information
Anne Wallis
Title:
Chief Operating Officer
Fax:
(604) 708-5883
Sarah Johnson
Title:
Executive Assistant
Telephone:
(604) 708-5858
Fax:
(604) 708-5883
Email:
Click Here
Products
Pharmaceuticals
Services